Why aspirin's antiplatelet effect lasts for the platelet's lifespan
Aspirin permanently disables an enzyme in platelets, so its antiplatelet effect (less platelet clumping) lasts for the platelet's entire lifespan.
Remember
Aspirin leaves the plasma quickly, but it permanently disables the enzyme in each affected platelet and platelets cannot make more, so function returns only as new platelets are made.
Aspirin blocks an enzyme called cyclo-oxygenase-1 (COX-1) inside platelets. It acetylates the enzyme, which means it attaches a small acetyl chemical tag, and the block is irreversible, meaning permanent. With COX-1 disabled, the platelet cannot make thromboxane A2, a chemical that promotes platelet aggregation (platelets sticking together).
The key is that platelets have no nucleus. A platelet is a cell fragment, so it cannot make new COX-1 to replace the disabled enzyme. The block therefore lasts for the entire platelet lifespan of 7 to 10 days.
This is why the drug's own half-life does not set how long the effect lasts. The half-life describes how quickly the drug leaves the plasma, and for aspirin it is only about 20 minutes. The antiplatelet effect lasts far longer than that.
Recovery depends on the bone marrow. New platelets enter the blood with working COX-1 and are not blocked, so the effect wears off gradually as the platelet population is replaced. Waiting for the drug level to fall therefore does not reverse it.
New platelets keep arriving, so a daily dose is needed to disable each new batch. For long-term use, the antiplatelet dose is typically 75 mg daily.
Key facts
- Target
- aspirin irreversibly acetylates COX-1 in platelets.
- Effect
- less thromboxane A2 is made, so there is less platelet aggregation.
- Why it persists
- platelets have no nucleus, so they cannot make new COX-1.
- Duration
- the effect lasts for the platelet's 7 to 10 day lifespan.
- Half-life
- aspirin's own plasma half-life is only about 20 minutes.
- Recovery
- it depends on new platelets from the bone marrow, not on the drug being cleared.
Exam traps
- A long plasma half-life does not explain aspirin's lasting effect, because the half-life is only about 20 minutes and the effect persists because the enzyme block is irreversible.
- Aspirin does not build up in fat to form a store of drug: its long effect comes from permanent enzyme inhibition, not from persisting drug levels.
- Aspirin does not remove thromboxane receptors from platelets: it stops thromboxane A2 being made, so the receptors remain but there is little thromboxane to activate them.
Read the full notes
Tested in 7 SimpleMed+ questions
Practice it in Pharmacology, with the answer and a full explanation after every question.
Practice these questions